Guideline adherence is suboptimal for chlamydia, gonorrhea treatment
Across primary care practices, guideline adherence remains suboptimal for chlamydia and gonorrhea, according to a study ...
CIDRAP8d
Non-adherent treatment for chlamydia, gonorrhea common in primary care
For all treated chlamydia infections, 14.0% of patients received doxycycline—the CDC's recommended treatment—alone or with ...
EurekAlert!9d
Many patients with chlamydia and gonorrhea are not receiving CDC-recommended treatment in primary care
This study aimed to quantify the overall treatment rate for chlamydia and gonorrhea and identify factors associated with treatment delays and disparities.
PharmiWeb8h
Labcorp to Offer HPV and STI Self-Collection Options in Labcorp Patient Service Centers and Participating Physician Offices Nationwide
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it will offer ...
News-Medical.Net on MSN8d
Disparities identified in treatment of chlamydia and gonorrhea in primary care
Prompt treatment of chlamydia and gonorrhea following a confirmed diagnosis is essential to prevent complications and reduce ...
FDA approves first at-home, over-the-counter test for STIs. But there's a catch.
The FDA announced Friday that it had approved the first at-home test for sexually transmitted infections, opening the pathway ...
MPR5d
FDA Clears OTC Test for Chlamydia, Gonorrhea and Trichomoniasis
The Food and Drug Administration (FDA) has cleared the Visby Medical Women’s Sexual Health Test for use at home to test for ...
PharmExec5d
FDA Grants Fast Track Designation to Sanofi’s mRNA Chlamydia Vaccine
As part of the Fast Track designation, Sanofi is set to launch a Phase I/II trial to evaluate the immunogenicity and safety of its novel mRNA vaccine in preventing chlamydia.
Dermatology Advisor2d
Universal Opt-Out Screening Improves STI Test Rates in Adolescents
Universal opt-out programs raise sexually transmitted infection screening rates in adolescents, though confidentiality issues may affect commercially insured patients.
FDA OKs first at-home test for 3 STIs
Visby Medical’s at-home diagnostic, which can be purchased without a prescription, tests for chlamydia, gonorrhea and ...